The global Drug Device Combination Products Market Growth Accelerated by Enhanced Innovation
Drug device combination products have become an attractive approach for pharmaceutical companies as it enables the delivery of therapeutics in a more effective manner. Drug device combination products involve medical devices that are used to administer pharmaceutical compounds, vaccines, or biologics to patients. These products integrate drugs with medical devices and are regulated through a single investigational new drug application or new drug application by the U.S. FDA. Some key advantages of drug device combination products include improved patient compliance, targeted drug delivery, and ability to deliver complex biologics. The global Drug Device Combination Products Market is estimated to be valued at US$ 150.23 Bn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The enhanced innovation in drug delivery systems is expected to be a key trend drivi...